| Discipline name | D-Index | World Ranking | Current World Ranking | National Ranking | Current National Ranking | Publications | Citations |
|---|---|---|---|---|---|---|---|
| Molecular Biology | 41 | 3048 | 2772 | 1443 | 1298 | 84 | 9541 |
The chart shows the history of publications by Arthur M. Buchberg between 1985 and 2016, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Arthur M. Buchberg published across 32 years, from 1985 to 2016, averaging 2.8 papers a year. Output peaked at 9 publications in 1990. 1 of the 89 publications appeared in the last two years.
89 publications in total across all disciplines
| Year | Publications |
|---|---|
| 1985 | 1 |
| 1986 | 2 |
| 1987 | 0 |
| 1988 | 2 |
| 1989 | 6 |
| 1990 | 9 |
| 1991 | 4 |
| 1992 | 2 |
| 1993 | 3 |
| 1994 | 8 |
| 1995 | 9 |
| 1996 | 7 |
| 1997 | 5 |
| 1998 | 5 |
| 1999 | 2 |
| 2000 | 0 |
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 0 |
| 2014 | 1 |
| 2015 | 0 |
| 2016 | 1 |
| Total | 89 |
The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Arthur M. Buchberg sits on this spectrum.
This scientist: 84 publications — 5th percentile
5% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 564 publications or more.
| Publications | Scientists | This scientist |
|---|---|---|
| 47–56 | 7 | |
| 57–66 | 17 | |
| 67–76 | 65 | |
| 77–86 | 90 | 84 |
| 87–96 | 125 | |
| 97–106 | 131 | |
| 107–116 | 162 | |
| 117–126 | 177 | |
| 127–136 | 158 | |
| 137–146 | 158 | |
| 147–156 | 146 | |
| 157–166 | 159 | |
| 167–176 | 131 | |
| 177–186 | 110 | |
| 187–196 | 112 | |
| 197–206 | 100 | |
| 207–216 | 89 | |
| 217–226 | 98 | |
| 227–236 | 74 | |
| 237–246 | 72 | |
| 247–256 | 63 | |
| 257–266 | 53 | |
| 267–276 | 54 | |
| 277–286 | 49 | |
| 287–296 | 52 | |
| 297–306 | 43 | |
| 307–316 | 46 | |
| 317–326 | 41 | |
| 327–336 | 42 | |
| 337–346 | 31 | |
| 347–356 | 28 | |
| 357–366 | 29 | |
| 367–376 | 26 | |
| 377–386 | 24 | |
| 387–396 | 24 | |
| 397–406 | 14 | |
| 407–416 | 13 | |
| 417–426 | 20 | |
| 427–436 | 12 | |
| 437–446 | 20 | |
| 447–456 | 11 | |
| 457–466 | 10 | |
| 467–476 | 14 | |
| 477–486 | 14 | |
| 487–496 | 10 | |
| 497–506 | 13 | |
| 507–516 | 13 | |
| 517–526 | 2 | |
| 527–536 | 4 | |
| 537–546 | 6 | |
| 547–556 | 8 | |
| 557–563 | 6 | |
| 564+ | 100 |
The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Arthur M. Buchberg sits on this spectrum.
This scientist: 41 D-Index — 1st percentile
1% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 145 D-Index or more.
| D-Index | Scientists | This scientist |
|---|---|---|
| 40–41 | 36 | 41 |
| 42–43 | 101 | |
| 44–45 | 115 | |
| 46–47 | 121 | |
| 48–49 | 118 | |
| 50–51 | 130 | |
| 52–53 | 106 | |
| 54–55 | 116 | |
| 56–57 | 113 | |
| 58–59 | 129 | |
| 60–61 | 120 | |
| 62–63 | 105 | |
| 64–65 | 131 | |
| 66–67 | 95 | |
| 68–69 | 97 | |
| 70–71 | 106 | |
| 72–73 | 83 | |
| 74–75 | 89 | |
| 76–77 | 77 | |
| 78–79 | 70 | |
| 80–81 | 73 | |
| 82–83 | 60 | |
| 84–85 | 48 | |
| 86–87 | 45 | |
| 88–89 | 50 | |
| 90–91 | 31 | |
| 92–93 | 51 | |
| 94–95 | 43 | |
| 96–97 | 38 | |
| 98–99 | 39 | |
| 100–101 | 41 | |
| 102–103 | 29 | |
| 104–105 | 33 | |
| 106–107 | 35 | |
| 108–109 | 20 | |
| 110–111 | 38 | |
| 112–113 | 19 | |
| 114–115 | 28 | |
| 116–117 | 13 | |
| 118–119 | 23 | |
| 120–121 | 16 | |
| 122–123 | 15 | |
| 124–125 | 11 | |
| 126–127 | 21 | |
| 128–129 | 7 | |
| 130–131 | 13 | |
| 132–133 | 14 | |
| 134–135 | 17 | |
| 136–137 | 9 | |
| 138–139 | 8 | |
| 140–141 | 16 | |
| 142–143 | 7 | |
| 144 | 7 | |
| 145+ | 100 |
Arthur M. Buchberg is affiliated with Bayer in the United States. Their professional association with this major pharmaceutical and life sciences company situates them within a dynamic environment of applied research and development.
Information about Arthur M. Buchberg's recent research papers, co-authors, main fields of study, subfields, and specific scientific topics is not available. Similarly, there are no recorded publications in academic journals or books attributed to this scientist in the source data provided.
While there are no listed awards or recognitions for Arthur M. Buchberg, the connection to Bayer indicates involvement in research areas likely related to biotechnology, pharmaceuticals, or chemical sciences, as these are key sectors of the company's focus.
No specific details about co-authors or collaborative networks have been documented, which suggests either a more individual research approach or data unavailability in this context.
The lack of designated research topics, subfields, and publication venues prevents a detailed mapping of Arthur M. Buchberg's scholarly contributions or specializations. However, their professional role at Bayer places them within a broad scientific landscape that could include pharmaceutical research, drug development, or agricultural sciences.
Arthur M. Buchberg is currently living, and no timeline or additional career milestones are provided. The information reflects a snapshot without comprehensive academic metrics or bibliometric indicators.
David Viskochil;Arthur M. Buchberg;Gangfeng Xu;Richard M. Cawthon
Melina MacPhee;Kenneth P Chepenik;Rebecca A Liddell;Kelly K Nelson
Camilynn I. Brannan;Archibald S. Perkins;Kristine S. Vogel;Nancy Ratner
John J. Moskow;Florencia Bullrich;Kay Huebner;Ira O. Daar
Linda D. Siracusa;Rodney McGrath;Qing Ma;John J. Moskow
U Suter;J J Moskow;A A Welcher;G J Snipes
Arthur M. Buchberg;Linda S. Cleveland;Nancy A. Jenkins;Neal G. Copeland
Wade H. Berrettini;Thomas N. Ferraro;Robert C. Alexander;Arthur M. Buchberg
Arthur M. Buchberg;Elise Brownell;Shigukazu Nagata;Nancy A. Jenkins
Galvin H. Swift;Ying Liu;Scott D. Rose;Larry J. Bischof
Qing Ma;Hansjuerg Alder;Kelly K. Nelson;Devjani Chatterjee
Richard M. Cawthon;Peter O'Connell;Arthur M. Buchberg;David Viskochil
T Scholzen;M Solursh;S Suzuki;R Reiter
Richard M. Cawthon;Lone B. Andersen;Arthur M. Buchberg;Gangfeng Xu
Mary E. Dickinson;Michael S. Kobrin;Colleen M. Silan;David M. Kingsley
Hisanori Kurooka;Keizo Kato;Shigeru Minoguchi;Yoshinori Takahashi
A. M. Buchberg;H. G. Bedigian;B. A. Taylor;E. Brownell
O Reiner;U Albrecht;M Gordon;KA Chianese
Arthur M. Buchberg;Hendrick G. Bedigian;Nancy A. Jenkins;Neal G. Copeland
L. D. Siracusa;A. M. Buchberg;Neal G. Copeland;Nancy A. Jenkins
If you think any of the details on this page are incorrect, let us know.
Exploring online degrees can offer flexible options for students interested in molecular biology and related health sciences. Many choose accelerated paths to advance their careers quickly. For those with an RN license, the fastest rn to bsn program options allow completion in as little as six months, which is ideal for working professionals.
If you already have an ADN, pursuing an adn to np program provides a direct bridge to advanced nursing roles and increased career potential. Even non-nurses can take advantage of direct entry msn programs online to launch a career in nursing, leveraging their science background for faster entry into high-demand positions.
With so many online options, it’s important to compare programs to find the right fit. Resources that examine differences between popular schools such as wgu vs chamberlain can guide your decision with insights into program structure, affordability, and outcomes. These pathways give science and molecular biology students new opportunities to enter specialized careers in healthcare and research.
